{"anticipatedPostingDate":"2027-03","denomUnitsSelected":"Participants","reportingStatus":"NOT_POSTED","timeFrame":"From treatment initiation till study completion","title":"SSA: Pre- and Post-dose Concentrations of Elranatamab- Phase 1b","type":"SECONDARY"}